Publications by authors named "Joep Perk"

Claim this Profile
A
A short history of the European Association of Preventive Cardiology (EAPC).
Guy De Backer, Joep Perk, David Wood, Stephan Gielen, Antonio Pelliccia

Eur J Prev Cardiol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self-perceived muscle side effects.
Elise Sverre, Kari Peersen, Oscar Kristiansen, Morten W Fagerland, Joep Perk

J Intern Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live longer? Stay physically active and keep your weight constant!
Joep Perk

Eur J Prev Cardiol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EAPC's 'Country of the Month' prevention web section going global.
Arne Janssen, Joep Perk, Arno Hoes, Paul Dendale

Eur J Prev Cardiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rise and fall of e-cigarettes according to Aesop.
Joep Perk

Eur J Prev Cardiol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.
Kari Peersen, John Munkhaugen, Elise Sverre, Oscar Kristiansen, Morten Fagerland, Joep Perk

BMC Cardiovasc Disord· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial.
Oscar Kristiansen, Nils Tore Vethe, Kari Peersen, Morten Wang Fagerland, Elise Sverre, Joep Perk

Eur Heart J Cardiovasc Pharmacother· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease.
Oscar Kristiansen, Elise Sverre, Kari Peersen, Morten Wang Fagerland, Erik Gjertsen, Joep Perk

Atherosclerosis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising implementation of European guidelines on cardiovascular disease prevention in clinical practice: what is needed?
Izabella Uchmanowicz, Arno Hoes, Joep Perk, Gabrielle McKee, Margrét Hrönn Svavarsdóttir

Eur J Prev Cardiol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintaining physical activity in patients after acute coronary syndromes, the challenge remains.
Joep Perk

Eur J Prev Cardiol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical and Psychosocial Factors Associated With Low Physical Activity and Increasing Exercise Level After a Coronary Event.
Kari Peersen, Jan Erik Otterstad, Elise Sverre, Joep Perk, Lars Gullestad

J Cardiopulm Rehabil Prev· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin-associated muscle symptoms in coronary patients: design of a randomized study.
John Munkhaugen, Nils Tore Vethe, Morten Wang Fagerland, Toril Dammen, Joep Perk

Scand Cardiovasc J· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESC Advocacy works!
Lina Badimon, Joep Perk

Eur Heart J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Too much of a good thing?
Joep Perk

Eur Heart J· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the rates of stroke and acute coronary events in northern France.
Joep Perk

Eur J Prev Cardiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.
John Munkhaugen, Jøran Hjelmesæth, Jan Erik Otterstad, Ragnhild Helseth, Stina Therese Sollid, Joep Perk

BMC Cardiovasc Disord· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum uric acid levels are associated with cardiovascular risk score: A post hoc analysis of the EURIKA study.
Claudio Borghi, Fernando Rodriguez-Artalejo, Guy De Backer, Jean Dallongeville, Jesús Medina, Joep Perk

Int J Cardiol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal blood pressure control after coronary events: the challenge remains.
Elise Sverre, Kari Peersen, Jan Erik Otterstad, Lars Gullestad, Joep Perk

J Am Soc Hypertens· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].
Massimo F Piepoli, Arno W Hoes, Stefan Agewall, Christian Albus, Carlos Brotons, Joep Perk

G Ital Cardiol (Rome)· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of cardiac rehabilitation in secondary prevention after coronary events.
Kari Peersen, John Munkhaugen, Lars Gullestad, Toril Liodden, Torbjorn Moum, Joep Perk

Eur J Prev Cardiol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
John Munkhaugen, Elise Sverre, Jan E Otterstad, Kari Peersen, Erik Gjertsen, Joep Perk

Eur J Prev Cardiol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
Julian P Halcox, José R Banegas, Carine Roy, Jean Dallongeville, Guy De Backer, Joep Perk

BMC Cardiovasc Disord· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2016 version of the European Guidelines on Cardiovascular Prevention.
Joep Perk

Eur Heart J Cardiovasc Pharmacother· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New care model for prevention after acute coronary artery disease].
Joep Perk, Gunilla Burell, Kristina Hambraeus, Catrin Henriksson, Roland Carlsson

Lakartidningen· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A healthy lifestyle in focus of new guidelines].
Joep Perk, Stefan Agewall, Anna Kiessling

Lakartidningen· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis